Clinical Trials List
Protocol NumberD9470C00001
Active
2023-12-01 - 2027-11-30
Phase I/II
Recruiting2
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 林明恩 Division of General Internal Medicine
- - - Division of Hematology & Oncology
- 李思慧 Division of Family Medicine
- MING YAO Division of General Internal Medicine
- Wen-Chien Chou Division of Others -
- YAO CHI-YUAN Division of Others -
- 田豐銘 Division of General Internal Medicine
- Chien-Chin Lin Division of Others -
- CHENG-HONG TSAI Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ya-Ting Hsu 無
- Sin-Syue Li 無
- 傅蓓安 Division of General Internal Medicine
- Ya-Ping Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
178 participants
